Illumina snares sequencing tech in $60M buyout

Illumina has struck a $60 million deal to enhance its genetic sequencing technology with the acquisition of Avantome. Avantome's owners will get $25 million of that upfront with the rest coming in contingency payments. And company founders Mostafa Ronaghi and Helmy Eltoukhy say they will take a place in Illumina's management team.

- read the AP story

Related Articles:
Illumina offers understanding of molecular mechanisms
Illumina focuses on molecular diagnostics
Four companies lead genome sequencing race
Illumina to buy Solexa for $600M